Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Persons with Multiple Sclerosis (PwMS) are physically inactive and spend more time in sedentary behaviours than healthy persons, which increases the risk of developing cardiometabolic diseases. In this randomised crossover study, the cardiometabolic health effects of replacing sitting with light-intensity physical activity (LIPA) and exercise (EX) were investigated.

Materials And Methods: Twenty-eight mildly disabled PwMS performed four 4-day activity regimens in free-living conditions; CONTROL (habitual activity), SIT, LIPA, and EX. Plasma glucose and insulin (oral glucose tolerance test), plasma lipids, inflammation, resting heart rate, blood pressure, body weight, and perceived exertion were measured (clinical-trials.gov: NCT03919058).

Results: CONTROL: 9.7 h sitting/day, SIT: 13.3 h sitting/day, LIPA: 8.3 h sitting, 4.7 h standing, and 2.7 h light-intensity walking/day, and EX: 11.6 h sitting/day with 1.3 h vigorous-intensity cycling. Compared to SIT, improvements ( < 0.001) after LIPA and EX were found for insulin total area under the curve (-17 019 ± 5708 and -23 303 ± 7953 pmol/L*min), insulin sensitivity (Matsuda index +1.8 ± 0.3 and +1.9 ± 0.4) and blood lipids (triglycerides: -0.4 ± 0.1 and -0.5 ± 0.1 mmol/L; non-high-density lipoprotein cholesterol: -0.3 ± 0.1 and -0.5 ± 0.1 mmol/L), with no difference between LIPA and EX. Perceived exertion was higher after EX compared to LIPA (Borg score [6-20]: +2.6 ± 3.3,  = 0.002).

Conclusion: Replacing sitting with LIPA throughout the day exerts similar cardiometabolic health effects as a vigorous-intensity exercise in PwMS.IMPLICATIONS FOR REHABILITATIONIncreasing light-intensity physical activity (LIPA) throughout the day improves cardiometabolic health to the same extent as one vigorous-intensity exercise sessionIncreasing LIPA induces less exertion than performing a vigorous-intensity exercise.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09638288.2022.2122601DOI Listing

Publication Analysis

Top Keywords

replacing sitting
8
sitting light-intensity
8
light-intensity physical
8
physical activity
8
cardiometabolic health
8
health effects
8
multiple sclerosis
8
activity
4
activity day
4
day versus
4

Similar Publications

Targeted intraoperative radiotherapy (IORT) delivers a single dose of radiation to a fresh tumour bed immediately after lumpectomy, commonly used to treat early breast cancer (EBC). It is delivered during the same sitting, with improved patient compliance and better sparing of adjacent healthy tissue, compared to conventional adjuvant radiotherapy to the whole breast. The recently published 12-year results (median follow up of 8.

View Article and Find Full Text PDF

Background: Physical activity (PA) and sedentary behavior (SB) are movement behaviors that have been associated with mental health. Evidence suggests that replacing SB with PA may influence mental disorders. This study aimed to evaluate the effects of replacing time spent in SB with moderate-intensity PA (MPA) and vigorous-intensity (VPA) on the symptoms of anxiety and depression among college students.

View Article and Find Full Text PDF

The direct anterior approach (DAA) for total hip arthroplasty (THA) has gained increasing popularity; however, the incidence, causes and outcomes of dislocations following THA are rarely studied. This study aims to evaluate the incidence, causes, and outcomes of dislocations following DAA THA. This retrospective study included 2933 patients who underwent DAA THA for osteoarthritis between 2014 and 2019, with a one-year follow-up.

View Article and Find Full Text PDF

Introduction: Skin blisters occur due to increased shear forces at the dermo-epidermal junction. They are classified as clear and hemorrhagic blisters. Blisters occur due to trauma, compartment syndrome, and vascular deficits.

View Article and Find Full Text PDF

Background: OFELIA aimed to evaluate outcomes related to safety and motor milestones following administration of onasemnogene abeparvovec, a one-time gene replacement therapy, for patients with spinal muscular atrophy (SMA) from Latin America.

Methods: OFELIA (NCT05073133) is a phase 4, 18-month, open-label, multicenter, non-randomised study (Brazil, Argentina) of onasemnogene abeparvovec treatment (1·1 × 10 vg/kg) for symptomatic patients with SMA ≤24 months of age and ≤17 kg (grouped by age [0-12 vs >12-24 months] and weight [<8·5 kg vs ≥8·5 kg]). The primary endpoint was safety.

View Article and Find Full Text PDF